Tue 27 Oct 2026 20:50:07 BST

Search Company

OMS Organisation Identifier:

OMS Location Identifier:

NCA Reference Key:

Address:

Country:

Active Substance

New Active Substance

Search Site

Create Site

Update Site

Current data stored in EudraGMDP database

Current data stored in OMS

DUNS Number:

NCA Reference Key:

Site Name:

OMS Organisation Identifier:

OMS Location Identifier:

Address Line 1:

Address Line 2:

Address Line 3:

Address Line 4:

City:

County:

Postcode:

Country:

Additional Details on Units Inspected

Site under Compliance Management:

Compliance Management comments:

Characters remaining:4000/4000

Overwrite with current OMS data.:

New Active Substance Importation

Active Substance*

Active Substance (English):
Active Substance (NL):
NCA Reference Key:

3rd Country Manufacturer

3rd Country Manufacturer	OMS Location Identifier	OMS Organisation Identifier	Legal Address	NCA Reference Key	Confidential	Edit	Delete
No records found.

3rd Country Distributor

3rd Country Distributor	OMS Location Identifier	OMS Organisation Identifier	Legal Address	NCA Reference Key	Confidential	Edit	Delete
No records found.

RTF Template

Hessian Office For Health And Care

UNION FORMAT FOR A WHOLESALE DISTRIBUTION AUTHORISATION

Human medicinal products

1. Authorisation Number	:	DE_HE_01_WDA_2025_0015
2. Name of Authorisation Holder	:	Lilly Deutschland GmbH (ORG-100002505 / LOC-100001395)
3. Address(es) of Site(s)	:	Werner-Reimers-Strasse 2-4, Bad Homburg, 61352, Germany

4. Legally registered address of Authorisation Holder	:	Werner-Reimers-Strasse 2-4, Bad Homburg, 61352
5. Scope of authorisation	:	ANNEX 1
6. Legal basis of authorisation	:	Sect 52a para 1 German Medicinal Product Act
7. Name of responsible officer of the competent authority of the member state granting the wholesale distribution authorisation	:	Confidential, Confidential
8. Signature	:
9. Date	:	2025-10-01
10. Annexes attached	:	Annex 1 Scope of wholesale distribution authorisation Annex 2 (Optional) Address(es) of contract wholesale distribution sites and their authorisation number Annex 3 (Optional) Name(s) of responsible person(s) Annex 4 (Optional) Date of Inspection on which authorisation was granted Annex 5 (Optional) Additional provisions based on national requirements

ANNEX 1

SCOPE OF WHOLESALE DISTRIBUTION AUTHORISATION

Name and address of the site: Lilly Deutschland GmbH

(ORG-100002505 / LOC-100001395)

, Werner-Reimers-Strasse 2-4, Bad Homburg, 61352, Germany

Human medicinal products

1. MEDICINAL PRODUCTS

1.1. with a Marketing Authorisation or registration in EEA country(s)

2. AUTHORISED WHOLESALE DISTRIBUTION OPERATIONS

2.1. Procurement

2.3. Supply

2.5. Other activities(s): (please specify) holding and supply as an outsourced activity in an external warehouse (see Annex 2)Lagerung und Lieferung (Abgabe) in einem beauftragten Betrieb (Anlage 2)

3. MEDICINAL PRODUCTS WITH ADDITIONAL REQUIREMENTS

3.1. Narcotic or psychotropic products**

Any restrictions or clarifying remarks (for all users): 3.1.3 Immunological medicinal products
3.1.4 Radiopharmaceuticals (including radionuclide kits); supply only by drop shipment
3.3 Cold chain products (requiring low temperature handling)

3.1.3 immunologische Arzneimittel
3.1.4 radioaktive Arzneimittel (einschließlich Radionuklidkits); Handel erfolgt im Streckengeschäft (Handel ohne Lagerung).
3.3 Kühlkettenpflichtige Arzneimittel (Lagerung und Transport bei niedrigen Temperaturen)

**Without prejudice to further authorisations as may be required according to national legislation.

Union Format for a Wholesale Distribution Authorisation	DE_HE_01_WDA_2025_0015
	Page 1

Loading, please wait